Vaccine Adjuvants- FDA & CDC

The patient safety and efficacy of adjuvants are highly required as the vaccines are one of the lifesaving agents. Therefore, the FDA and CDC rules regarding the vaccine adjuvants are highly essential during vaccine formulation and manufacturing processes. CBER of FDA is responsible for vaccine regulation in the United States. Vaccine development process follows the same pathway as for drugs and other pharmaceutical agents. A sponsor must submit the Investigational New Drug application (IND) to FDA. The IND describes about the vaccine, quality control tests for release, and its method of manufacture. After the successful completion of all three phases of clinical development the Biologics License Application (BLA) are submitted. After getting the permission form FDA and CDC a vaccine may be marketed.

  • FDA Approved Vaccine Adjuvants
  • Factors Effecting Vaccine Preservation
  • Efficacy of Vaccines in Newborns
  • Pre-Formulation & Formulation Aspects
  • Vaccine Ingredients
  • Vaccines During Pregnancy
  • Vaccine Safety Monitoring

Mail us at

Program Manager
vaccinedelivery@alliedmeetings.com
Abstract Submission
vaccinedelivery@alliedmeetings.com
Sponsors and Exhibitors
vaccinedelivery2017@protonmail.com
More details about sponsorship:sponsors@alliedacademies.com
Copyright © 2017-2018 Allied Academies, All Rights Reserved.